Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Compound 4 is a promising treatment for hair loss with low toxicity.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Alitretinoin may help treat alopecia areata.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Deucravacitinib may effectively treat discoid lupus erythematosus.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

The compound 4c showed strong potential as an anticancer agent.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

GI197111X is best dissolved in Capmul MCM for trials.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

CXCR2 in skin cells promotes tumor growth.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.